0J6Z.L

Humana Inc. [0J6Z.L] Stock Forecast

Q: What is Humana Inc. stock symbol ?

Humana Inc. is a US stock, located in Louisville of Ky and trading under the symbol 0J6Z.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0J6Z.L Stock Summary

Earnings have grown 14.55% per last year.

The Moving Average Convergence Divergence (MACD) for 0J6Z.L recently turned positive (within last 10 days).

0J6Z.L has more than 12 years of cash runway (153 months)

Earnings are expected to fall -100% next year

Unstable dividend track record

EPS has been decreasing for the past 3 years (Yearly statements)

EPS has been decreasing for the past 3 quarters (Quarter statements)

Top 10 Correlated ETFs

0J6Z.L

Top 10 Correlated Stocks

0J6Z.L

In the News

0J6Z.L Financial details

Company Rating

Buy

Market Cap

37.72B

Income

2.49B

Revenue

106.37B

Book val./share

132.79

Cash/share

174.1

Dividend

3.54

Dividend %

0.77%

Employees

67.6K

Optionable

Shortable

Yes

Earnings

24 Apr 2024

P/E

23.83

Forward P/E

PEG

-23.31

P/S

0.79

P/B

2.16

P/C

1.89

P/FCF

6.12

Quick Ratio

Current Ratio

Debt / Equity

0.73

LT Debt / Equity

0.63

EPS (TTM)

19.93

EPS next Y

EPS next Q

EPS this Y

-9.5%

EPS next Y

EPS next 5Y

EPS last 5Y

-0.1%

Revenue last 5Y

10.39%

Revenue Q/Q

0.15%

EPS Q/Q

-165.58%

SMA20

-7.76%

SMA50

-13.24%

SMA100

-36.81%

Inst Own

Inst Trans

ROA

ROE

ROC

Gross Margin

100%

Oper. Margin

Profit Margin

Payout

12%

Shs Outstand

Shs Float

Target Price

52W Range

312.01-541.1153

52W High

-39.29%

52W Low

+5.28%

RSI

Rel Volume

0.79

Avg Volume

1.96K

Volume

1.56K

Perf Week

3.31%

Perf Month

-3.2%

Perf Quarter

-36.66%

Perf Half Y

-37.16%

Beta

0.463

Volatility

5.81%, 16.11%

Prev Close

0.49%

Price

328.465

Change

-0.06%

0J6Z.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	484.38	583.9	650.01	735.03	859.32
Net income per share	20.19	25.47	22.79	22.2	20.09
Operating cash flow per share	39.42	42.66	17.58	36.28	32.14
Free cash flow per share	33.93	35.36	7.35	27.42	24.03
Cash per share	112.09	130.31	128.89	149.84	172.12
Book value per share	89.79	103.84	124.95	121.11	131.29
Tangible book value per share	59.17	67.72	18.43	35.3	54.64
Share holders equity per share	89.79	103.84	124.95	121.11	131.29
Interest debt per share	44.94	53.5	101.06	92.53	99.45
Market cap	48.91B	54.2B	60.07B	64.32B	56.46B
Enterprise value	50.97B	56.67B	69.91B	71.01B	64.03B
P/E ratio	18.07	16.1	20.48	22.92	22.68
Price to sales ratio	0.75	0.7	0.72	0.69	0.53
POCF ratio	9.26	9.61	26.56	14.02	14.18
PFCF ratio	10.75	11.59	63.5	18.55	18.97
P/B Ratio	4.06	3.95	3.74	4.2	3.47
PTB ratio	4.06	3.95	3.74	4.2	3.47
EV to sales	0.78	0.73	0.84	0.76	0.6
Enterprise value over EBITDA	15.79	12.91	22.61	22.42	74.55
EV to operating cash flow	9.65	10.05	30.9	15.48	16.08
EV to free cash flow	11.21	12.12	73.9	20.48	21.51
Earnings yield	0.06	0.06	0.05	0.04	0.04
Free cash flow yield	0.09	0.09	0.02	0.05	0.05
Debt to equity	0.48	0.49	0.79	0.74	0.73
Debt to assets	0.2	0.19	0.28	0.26	0.25
Net debt to EBITDA	0.64	0.56	3.18	2.11	8.82
Current ratio	1.82	1.77	1.62	1.52	1.59
Interest coverage	13.34	15.52	9.48	7.9	-0.12
Income quality	1.95	1.67	0.77	1.63	1.6
Dividend Yield	0.01	0.01	0.01	0.01	0.01
Payout ratio	0.11	0.1	0.12	0.14	0.17
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.14	0.14	0.31	0.25	0.2
Capex to operating cash flow	-0.14	-0.17	-0.58	-0.24	-0.25
Capex to revenue	-0.01	-0.01	-0.02	-0.01	-0.01
Capex to depreciation	-1.28	-1.56	-1.85	-1.33	-1.09
Stock based compensation to revenue	0	0	0	0	0
Graham number	201.98	243.94	253.14	245.94	243.63
ROIC	0.14	0.15	0.09	0.09	0
Return on tangible assets	0.11	0.11	0.09	0.09	0.07
Graham Net	-14.77	-31.18	-93.71	-74.46	-74.71
Working capital	8.96B	10.25B	9.56B	9.01B	11.11B
Tangible asset value	7.93B	8.95B	2.37B	4.46B	6.77B
Net current asset value	2.88B	2.29B	-3.75B	-2.17B	-588M
Invested capital	0.48	0.49	0.79	0.74	0.73
Average receivables	0	0	0	0	0
Average payables	1.88B	3.88B	4.26B	4.87B	5.9B
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	30.45K	40.69K	-3.02K	36.77K	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0.01	0.01	-0.12	0.01	0
Inventory turnover	0	0	0	0	0
ROE	0.22	0.25	0.18	0.18	0.15
Capex per share	-5.49	-7.29	-10.23	-8.86	-8.11

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	178.59	213.93	214.71	214.08	216.09
Net income per share	-0.12	9.91	7.7	6.74	-4.42
Operating cash flow per share	-40.81	53.49	25.49	10.14	-58.26
Free cash flow per share	-42.86	51.71	23.38	8.25	-60.57
Cash per share	150.76	229.33	252.58	245.43	174.1
Book value per share	121.86	132.61	135.13	137.32	132.79
Tangible book value per share	35.52	44.48	59.02	60.47	55.27
Share holders equity per share	121.86	132.61	135.13	137.32	132.79
Interest debt per share	90.77	93.78	95.24	95.94	97.75
Market cap	63.92B	61.03B	55.75B	60.82B	55.82B
Enterprise value	70.61B	58.91B	51.28B	57.4B	63.39B
P/E ratio	-1.07K	12.32	14.53	18.27	-25.79
Price to sales ratio	2.85	2.28	2.08	2.3	2.11
POCF ratio	-12.47	9.13	17.55	48.58	-7.82
PFCF ratio	-11.87	9.44	19.15	59.74	-7.53
P/B Ratio	4.17	3.68	3.31	3.59	3.43
PTB ratio	4.17	3.68	3.31	3.59	3.43
EV to sales	3.15	2.2	1.92	2.17	2.4
Enterprise value over EBITDA	-1.09K	39.67	234.16	255.1	297.62
EV to operating cash flow	-13.77	8.81	16.15	45.84	-8.89
EV to free cash flow	-13.11	9.11	17.61	56.38	-8.55
Earnings yield	0	0.02	0.02	0.01	-0.01
Free cash flow yield	-0.08	0.11	0.05	0.02	-0.13
Debt to equity	0.74	0.7	0.7	0.69	0.73
Debt to assets	0.26	0.21	0.21	0.21	0.25
Net debt to EBITDA	-102.95	-1.43	-20.41	-15.2	35.56
Current ratio	1.52	1.39	1.37	1.37	1.59
Interest coverage	-0.6	13.14	-0.06	-0.09	-0.17
Income quality	341.8	5.4	3.31	1.5	13.19
Dividend Yield	0	0	0	0	0
Payout ratio	-6.73	0.08	0.12	0.13	-0.21
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.25	0.2	0.17	0.17	0.2
Capex to operating cash flow	0.05	-0.03	-0.08	-0.19	0.04
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-1.13	-1.02	-1.17	-1	-1.19
Stock based compensation to revenue	0	0	0	0	0
Graham number	18.09	171.97	152.99	144.32	114.89
ROIC	0	0.04	0	0	0
Return on tangible assets	0	0.03	0.02	0.02	-0.01
Graham Net	-74.92	-75.8	-65.01	-69.74	-75.57
Working capital	9.01B	10.59B	10.48B	10.43B	11.11B
Tangible asset value	4.46B	5.56B	7.35B	7.46B	6.77B
Net current asset value	-2.17B	-610M	-805M	-648M	-588M
Invested capital	0.74	0.7	0.7	0.69	0.73
Average receivables	0	0	0	0	0
Average payables	6B	6.33B	7.77B	7.86B	7.08B
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0	0.07	0.06	0.05	-0.03
Capex per share	-2.05	-1.78	-2.12	-1.9	-2.31

0J6Z.L Dividend History

0J6Z.L Frequently Asked Questions

What is Humana Inc. stock symbol ?

Humana Inc. is a US stock , located in Louisville of Ky and trading under the symbol 0J6Z.L

What is Humana Inc. stock quote today ?

Humana Inc. stock price is $328.465 today.

Is Humana Inc. stock public?

Yes, Humana Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.96K
Market Capitalization 37.72B
Employee 67.6K
CEO Mr. Bruce Dale Broussard
Headquarters Louisville,KY,US
IPO Date 2018-01-29
Website https://www.humana.com

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.